Carnitine-acylcarnitine translocase deficiency: case report and review of the literature.

M E Rubio-Gozalbo, P Vos, P Ph Forget, S B Van Der Meer, R J A Wanders, H R Waterham, J A Bakker

Journal: Acta paediatrica (Oslo, Norway : 1992) 2003;92(4):501-4

PMID: 12801121

Abstract

AIM

Carnitine-acylcarnitine translocase (CACT) deficiency is an inborn error of metabolism involving the mitochondrial beta-oxidation of long-chain fatty acids. The aim of this study was to report on a new case (neonatal phenotype) and review the literature data on 24 previously reported cases.

METHODS

Clinical data of the new case are described and compared with the previous reports.

RESULTS

The patient with a novel mutation had clinical features and biochemical findings similar to those of the other reported patients.

CONCLUSION

CACT is an entity in which clinical encephalopathy, hepatomegaly and arrythmias are common. Hyperammonaemia and elevation of creatine kinase seem to be constant findings as in other disorders of mitochondrial beta-oxidation of long-chain fatty acids. The mortality rate is very high.

Address: Departments of Pediatrics, University Hospital Maastricht, The Netherlands. [email protected]

DOI: 10.1111/j.1651-2227.2003.tb00586.x

Link outs

Free resources

Medical:

http://babysfirsttest.org/newborn-screening/condit...

Subscription / membership required

Full Text Sources:

https://onlinelibrary.wiley.com/resolve/openurl?ge...

MeSH Terms: Carnitine Acyltransferases, Fatal Outcome, Female, Humans, Infant, Newborn, Metabolism, Inborn Errors